Abstract

Miller Fischer syndrome (MFS) is a rare clinical variant of Guillain-Barre syndrome. The diagnosis suspected primarily on clinical trial of areflexia, ophtalmoplegia and ataxia, is confirmed by the mandatory presence of antiganglioside antibodies (anti GQ1b). An acute onset is typical of MFS, beginning with neurological symptoms following a respiratory or digestive infectious illness. The therapeutic options are either the plasmapheresis or the administration of intravenous immunoglobulin (IVIG). Although rare, in certain cases the patients present with respiratory symptoms needing intensive care. We report the case report of a patient which presented with the classical triad of MFS but also with rapid progressive respiratory failure due to bilateral vocal cords palsy and general muscle weakness. He needed respiratory mechanical support. The patient received a treatment by IVIG without any improvement in symptomatology. Eventually he completely recovered and he was discharged from the hospital 3 month later.

Highlights

  • Miller Fisher syndrome associated with respiratory failure

  • The diagnosis suspected primarily on clinical Frentescu Alexandra trial of areflexia, ophtalmoplegia and ataxia, is confirmed by the Intensive Care Unit, Catholic Univemandatory presence of antiganglioside antibodies. rsity of Louvain, CHU UCL Namur, An acute onset is typical of Miller Fischer syndrome (MFS), beginning with neurological Avenue du Docteur G

  • We report the case report How to cite this article: of a patient which presented with the classical triad of MFS but Frentescu Alexandra, Feys Odile, with rapid progressive respiratory failure due to bilateral Mangion Jean-Paul, Osseman Micvocal cords palsy and general muscle weakness

Read more

Summary

Introduction

Miller Fisher syndrome associated with respiratory failure The diagnosis suspected primarily on clinical Frentescu Alexandra trial of areflexia, ophtalmoplegia and ataxia, is confirmed by the Intensive Care Unit, Catholic Univemandatory presence of antiganglioside antibodies (anti GQ1b). Fax: +32-81423862 rare, in certain cases the patients present with respiratory symptoms needing intensive care.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call